Evidence map›Paper›PMID 35328403›Full record

ArticleInternational journal of molecular sciences2022

Hyperforin and Myrtucommulone Derivatives Act as Natural Modulators of Wnt/β-Catenin Signaling in HCT116 Colon Cancer Cells.

Aneliya Knauthe, Sonnhild Mittag, Laura Bloch, Kai Frederik Albring, Martin Schmidt, Oliver Werz, Otmar Huber

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Four New Polyprenylated Acylphloroglucinols fromMolecules (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Aneliya KnautheInstitute of Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.ORCID 0000-0002-9258-4423
Sonnhild MittagInstitute of Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.
Laura BlochInstitute of Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.
Kai Frederik AlbringInstitute of Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.
Martin SchmidtInstitute of Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.ORCID 0000-0003-3578-4338
Oliver WerzDepartment of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, 07743 Jena, Germany.ORCID 0000-0002-5064-4379
Otmar HuberInstitute of Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, 07743 Jena, Germany.ORCID 0000-0003-4359-1747
Jena University Hospital · DEFriedrich Schiller University Jena · DE

Funding

Thueringer Universitaets- und Landesbibliothek DE 150546536
6 · The paper itself

Abstract

The therapeutic activities of natural plant extracts have been well known for centuries. Many of them, in addition to antiviral and antibiotic effects, turned out to have anti-tumor activities by targeting different signaling pathways. The canonical Wnt pathway represents a major tumorigenic pathway deregulated in numerous tumor entities, including colon cancer. Here, we investigated the acylphloroglucinols hyperforin (HF) from St. John's wort (

Indexed as

Colonic NeoplasmsHypericumbeta CateninHCT116 CellsHumansPhloroglucinolTerpenesWnt Signaling Pathwaybeta CateninhyperforinPhloroglucinolTerpenesacylphloroglucinolcell proliferationcolony formationhyperforinHypericum perforatum L. (St. John’s wort)myrtucommuloneMyrtus communisWnt/β-catenin signaling

Identifiers

PMID35328403
PMCPMC8954631
OpenAlexW4221094660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.